Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them generate a profit in the stock market.
Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them generate a profit in the stock market.
After a massive slip up last year, the tide appears to be turning for small cap vaccine maker Novavax (NVAX). In Wednesday’s trading session, shares took off and surged as
After a stock takes a tumble, wait just a minute before you count it out. While falling share prices could be a sign that a company is under duress, it
Exact Sciences’ (EXAS) preliminary quarterly results blew expectations out of the water. Yesterday, the molecular diagnostics company released preliminary results for its fourth quarter that exceeded analysts’ estimates. Total revenue
In a single day, the talk on the Street has zeroed in on one stock, oncology-focused cell therapy company Adaptimmune Therapeutics (ADAP). Following its presentation of promising data at the